Anas Hadeh is a Respiratory physician. OpenAlex indexes 62 publications with 1,630 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2950 Cleveland Clinic Blvd
Weston, FL 333313609
Telephone
954-659-5450Provider last certified this registry record 24 Apr 2024.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year2025100 payments$105,785openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202564 payments$57,286openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year202527 payments$48,884openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
84.2%Corticosteroid44.1%Trelegy Ellipta44%Fluticasone Propionate32%Breo Ellipta13%Symbicort8%Arnuity Ellipta4%Part D<11 patientsbeta2-Adrenergic Agonist13.7%Albuterol Sulfate Hfa100%Part D≥32 patients+ 5 more classes in this area
Anti-infectives
10.6%Macrolide Antimicrobial3.3%Azithromycin100%Part D<11 patientsAminoglycoside Antibacterial3%Arikayce100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
5.2%Corticosteroid5.2%Prednisone100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Bronchiectasis: Past insights, present clinical evidence, and future research pathways
Respiratory Medicine
2026 - Complications of Sickle Cell Disease Requiring Venovenous Extracorporeal Membrane Oxygenation
American Journal of Respiratory and Critical Care Medicine
2025 - Cystic-Fibrosis Transmembrane Conductance Regulator Related Metabolic Syndrome (CFTR) Develops Severe Cystic Fibrosis (CF) Bronchiectasis
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”